Status:
COMPLETED
Cohort Study Evaluating the Clinical Effectiveness, Safety and Immunogenicity to the Pandemic Influenza Vaccination
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
URC-CIC Paris Descartes Necker Cochin
Conditions:
Cystic Fibrosis With Gastrointestinal Manifestation
Eligibility:
All Genders
6+ years
Phase:
PHASE4
Brief Summary
Multicenter prospective cohort of approximately 1000 cystic fibrosis patients followed in the Ile de France during the 2009-2010 influenza season with the main objective to assess the effectiveness of...
Detailed Description
Main objective : To investigate the clinical efficacy of pandemic influenza vaccine (H1N1) v patients with cystic fibrosis (CF) Secondary objectives : Vaccine research * Measure the adherence of thi...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- patients with cystic fibrosis
Exclusion
Key Trial Info
Start Date :
November 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
439 Patients enrolled
Trial Details
Trial ID
NCT01499914
Start Date
November 1 2009
End Date
December 1 2012
Last Update
November 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Necker Hospital
Paris, France, 75015